Biblio

Author Title [ Type

] Year

Filters: Author is Tomuleasa, Ciprian [Clear All Filters]

Journal Article

Tatar A-S, Jurj A, Tomuleasa C, Florea A, Berindan-Neagoe I, Cialla-May D, Popp J, Astilean S, Boca S. CD19-targeted, Raman tagged gold nanourchins as theranostic agents against acute lymphoblastic leukemia. Colloids Surf B Biointerfaces. 2019;184:110478.

Tanase A, Tomuleasa C, Marculescu A, Bardas A, Colita A, Orban C, Ciurea SOctavian. Haploidentical Donors: Can Faster Transplantation Be Life-Saving for Patients with Advanced Disease?. Acta Haematol. 2016;135(4):211-216.

Mester A, Irimie AIulia, Tanase A, Tranca S, Campian RSeptimiu, Tomuleasa C, Dima D, Piciu A, Lucaciu O. Periodontal disease might be a risk factor for graft versus host disease. A systematic review. Crit Rev Oncol Hematol. 2020;147:102878.

Gaballa S, Ge I, Fakih REl, Brammer JE, Kongtim P, Tomuleasa C, Wang SA, Lee D, Petropoulos D, Cao K, et al. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation. Cancer. 2016.

Rani B, Cao Y, Malfettone A, Tomuleasa C, Fabregat I, Giannelli G. Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma. World J Gastroenterol. 2014;20(15):4128-4140.